These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 4545737

  • 1. Proceedings: In vivo inhibition of dopamine beta-hydroxylase and blood pressure.
    Hidaka H, Hara F, Harada N, Asano M.
    Jpn J Pharmacol; 1974; 24(0):s:25. PubMed ID: 4545737
    [No Abstract] [Full Text] [Related]

  • 2. Selective inhibition of dopamine-beta-hydroxylase in the peripheral tissues by 5-dimethyldithiocarbamylpicolinic acid; its effect on stress-induced ulcer, ethanol-induced sleep and blood pressure.
    Hidaka H, Hara F, Harada N, Hashizume Y, Yano M.
    J Pharmacol Exp Ther; 1974 Dec; 191(3):384-92. PubMed ID: 4473535
    [No Abstract] [Full Text] [Related]

  • 3. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
    Korduba CA, Veals J, Wohl A, Symchowicz S, Tabachnick II.
    J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Proceedings: Effect of a dopamine-beta-hydroxylase inhibitor (fusaric acid) on thyroid hormones and TSH].
    Yoshimura M, Yatani T, Ochi Y, Nagasaka A, Takeda A.
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb 20; 50(2):88. PubMed ID: 4476662
    [No Abstract] [Full Text] [Related]

  • 7. [Substituted picolinic acids as DBH inhibitors. Inhibition of dopamine beta-hydroxylase and antihypertensive action].
    Piesche L, Hilse H, Oehlke J, Schrötter E, Oehme P.
    Pharmazie; 1983 May 20; 38(5):335-8. PubMed ID: 6611632
    [Abstract] [Full Text] [Related]

  • 8. Analogues of fusaric (5-butylpicolinic) acid as potent inhibitors of dopamine -hydroxylase.
    Hidaka H, Asano T, Takemoto N.
    Mol Pharmacol; 1973 Mar 20; 9(2):172-7. PubMed ID: 4197141
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Behavioral depression in Sidman avoidance learning induced by dopamine beta-hydroxylase inhibitors.
    Tamaki Y, Hidaka H.
    Psychol Rep; 1976 Apr 20; 38(2):437-8. PubMed ID: 1265176
    [No Abstract] [Full Text] [Related]

  • 11. The effect of dopamine-beta-hydroxylase inhibitors, dimethylphenylthiourea and fusaric acid, on locomotor and exploratory activity, body temperature, and regional distribution of biogenic amines in the rat brain.
    Vetulani J, Reichenberg K, wiszniowska G, Marchaj J.
    Pol J Pharmacol Pharm; 1973 Apr 20; 25(6):559-72. PubMed ID: 4792476
    [No Abstract] [Full Text] [Related]

  • 12. Influence of dopamine-beta-hydroxylase inhibition on the cardiovascular and respiratory actions of dopamine in rats.
    Riancho JA, del Arco C, Pazos A, Flórez J.
    Rev Esp Fisiol; 1982 Dec 20; 38(4):461-9. PubMed ID: 7170431
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of fusaric acid on the membrane potential in left ventricle fragments from rats and rabbits.
    Richter R.
    Pharmazie; 1982 Oct 20; 37(10):736. PubMed ID: 7178221
    [No Abstract] [Full Text] [Related]

  • 15. Letter: Fusaric acid derivatives: the effect on dopamine beta-hydroxylase.
    Umezawa H, Takeuchi T, Miyano K, Koshigoe K, Hamano H.
    J Antibiot (Tokyo); 1973 Mar 20; 26(3):189. PubMed ID: 4205877
    [No Abstract] [Full Text] [Related]

  • 16. Picolinic acids as inhibitors of dopamine beta-monooxygenase: QSAR and putative binding site.
    Dove S.
    Arch Pharm (Weinheim); 2004 Dec 20; 337(12):645-53. PubMed ID: 15597398
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacology of fusaric acid in man.
    Matta RJ, Wooten GF.
    Clin Pharmacol Ther; 1973 Dec 20; 14(4):541-6. PubMed ID: 4269210
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of human serum dopamine -hydroxylase after the oral administration of fusaric acid.
    Nagatsu T, Kato T, Kuzuya H, Okada T, Umezawa H, Takeuchi T.
    Experientia; 1972 Jul 15; 28(7):779-80. PubMed ID: 4658852
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.